Synthetic Biology in Chimeric Antigen Receptor T (CAR T) Cell Engineering-Reference-Cited by-同舟云学术

Synthetic Biology in Chimeric Antigen Receptor T (CAR T) Cell Engineering

Published:2022-01-10 Issue:1 Volume:11 Page:1-15
ISSN:2161-5063
Container-title:ACS Synthetic Biology
language:en
Short-container-title:ACS Synth. Biol.

Author:

Zhang Cuilin¹²,Zhuang Qiuyu¹²,Liu Jingfeng¹³,Liu Xiaolong¹²^ORCID

Affiliation:

1. The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350025, P. R. China

2. The Liver Center of Fujian Province, Fujian Medical University, Fuzhou, 350025, P. R. China

3. Fujian Medical University Cancer Hospital, Fuzhou, 350014, P. R. China

Funder

Fujian Medical University

Fujian Provincial Health and Family Planning Commission

Natural Science Foundation of Fujian Province

Joint Funds for the Innovation of Science and Technology of Fujian Province

Publisher

American Chemical Society (ACS)

Subject

Biochemistry, Genetics and Molecular Biology (miscellaneous),Biomedical Engineering,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acssynbio.1c00256

Reference121 articles.

1. The market for chimeric antigen receptor T cell therapies

2. Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase I Trials

3. Targeting cardiac fibrosis with engineered T cells

4. Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse model

5. Senolytic CAR T cells reverse senescence-associated pathologies

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural killer (NK) cells-related gene signature reveals the immune environment heterogeneity in hepatocellular carcinoma based on single cell analysis;Discover Oncology;2024-09-04

2. Atypical artificial cells: Novel biomimetic materials for combating cancer;Interdisciplinary Materials;2024-07-17

3. Emerging roles of CAR-NK cell therapies in tumor immunotherapy: current status and future directions;Cell Death Discovery;2024-07-10

4. Understanding resource competition to achieve predictable synthetic gene expression in eukaryotes;Nature Reviews Bioengineering;2024-07-04

5. The Power of Imaging Techniques in CAR-T Cell Therapy Enhancement: Revolutionizing Cancer Treatment;Interdisciplinary Cancer Research;2024